| Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines X Liu, Y Zhang, S Zhou, L Dain, L Mei, G Zhu Journal of Controlled Release 348, 84-94, 2022 | 102 | 2022 |
| Small GTPases: Structure, biological function and its interaction with nanoparticles S Song, W Cong, S Zhou, Y Shi, W Dai, H Zhang, X Wang, B He, Q Zhang Asian journal of pharmaceutical sciences 14 (1), 30-39, 2019 | 78 | 2019 |
| Thiolated nanoparticles overcome the mucus barrier and epithelial barrier for oral delivery of insulin S Zhou, H Deng, Y Zhang, P Wu, B He, W Dai, H Zhang, Q Zhang, R Zhao, ... Molecular pharmaceutics 17 (1), 239-250, 2019 | 37 | 2019 |
| Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy T Su, F Cheng, J Qi, Y Zhang, S Zhou, L Mei, S Fu, F Zhang, S Lin, G Zhu Advanced science 9 (23), 2201895, 2022 | 34 | 2022 |
| The function and mechanism of preactivated thiomers in triggering epithelial tight junctions opening Y Zhang, S Zhou, F Deng, X Chen, X Wang, Y Wang, H Zhang, W Dai, ... European Journal of Pharmaceutics and Biopharmaceutics 133, 188-199, 2018 | 32 | 2018 |
| Delivery of nucleic acid therapeutics for cancer immunotherapy S Zhou, W Chen, J Cole, G Zhu Medicine in drug discovery 6, 100023, 2020 | 27 | 2020 |
| pH‐responsive STING‐activating DNA nanovaccines for cancer immunotherapy Y Zhang, T Shen, S Zhou, W Wang, S Lin, G Zhu Advanced therapeutics 3 (9), 2000083, 2020 | 24 | 2020 |
| Nucleic acid immunotherapeutics for cancer T Shen, Y Zhang, S Zhou, S Lin, XB Zhang, G Zhu ACS applied bio materials 3 (5), 2838-2849, 2020 | 18 | 2020 |
| Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect F Cheng, T Su, S Zhou, X Liu, S Yang, S Lin, W Guo, G Zhu Science advances 9 (28), eade6257, 2023 | 14 | 2023 |
| Targeting Lymph Nodes for Systemic Immunosuppression Using Cell‐Free‐DNA‐Scavenging And cGAS‐Inhibiting Nanomedicine‐In‐Hydrogel for Rheumatoid Arthritis Immunotherapy F Cheng, T Su, Y Liu, S Zhou, J Qi, W Guo, G Zhu Advanced Science 10 (26), 2302575, 2023 | 7 | 2023 |
| ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosis L Hu, W Chen, S Zhou, G Zhu Biophysics reports 6, 290-298, 2020 | 3 | 2020 |
| Engineering and delivery of cGAS-STING immunomodulators for the immunotherapy of cancer and autoimmune diseases S Zhou, F Cheng, Y Zhang, T Su, G Zhu Accounts of chemical research 56 (21), 2933-2943, 2023 | 2 | 2023 |
| Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy S Zhou, T Su, F Cheng, J Cole, X Liu, B Zhang, S Alam, J Liu, G Zhu bioRxiv, 2023 | 2 | 2023 |
| Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy S Zhou, T Su, F Cheng, J Cole, X Liu, B Zhang, S Alam, J Liu, G Zhu Molecular Therapy-Nucleic Acids 35 (1), 2024 | | 2024 |
| Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy T Su, S Zhou, S Yang, N Humble, F Zhang, G Yu, PD Bos, F Cheng, ... Theranostics 13 (13), 4304, 2023 | | 2023 |
| STING pathway and modulation for cancer immunotherapy T Su, NT Ahmed, S Zhou, X Liu, G Zhu Cancer Immunology and Immunotherapy, 353-373, 2022 | | 2022 |
